U.S. Administration efforts aimed at mitigating issues arising out of Beijing’s ‘Made in China 2025’

The U.S. Administration is increasingly boosting efforts to tilt, what has so far been so far in recent history, a one-sided affair, of collaboration and forced technology transfer from the U.S. to China. Beijing’s Made in China 2025 industrial policy has opened the administration’s eye to China’s furtive motives of leveraging the dual benefits of…

U.S. Supreme Court upholds legality of the Inter partes review process

To the chagrin of patent trolls and big pharma, in a ruling with widespread implications for high technology companies, including Apple and Samsung, U.S. Supreme Court justices in a 7-2 ruling upheld the IPR system. In a development with significant implications for tech companies, on Tuesday the U.S. Supreme Court approved of a government review…